» Articles » PMID: 28472149

Clinical Characteristics of Moderate-to-severe Thyroid Associated Ophthalmopathy in 354 Chinese Cases

Overview
Journal PLoS One
Date 2017 May 5
PMID 28472149
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Thyroid associated ophthalmopathy (TAO) is an autoimmune inflammatory disorder which disfigures appearance, threatens vision, and results in a pronounced loss of quality of life. The diversity and ethnic difference of the disease manifestations have made it difficult to tailor therapies for each patient. Few studies have analyzed its characteristics in Chinese populations. We therefore enrolled 354 patients with moderate-to-severe TAO from February 2015 to July 2016. A single ophthalmologist consistently performed detailed ophthalmic examinations. Orbital computed tomography or magnetic resonance imaging scans were performed to verify enlarged extraocular muscles. Multiple linear regression was used to analyze the association between sex, age, smoking, family history of thyroid diseases, degree of proptosis and disease severity. The mean age of males (46.56±11.08 years) was significantly higher than that of females (41.39±years), with a female-to-male ratio of 1.09. The females and males between 31~40 and 41~50 years, respectively, had the highest incidence of TAO. 81.48% of the patients suffered hyperthyroidism. TAO was diagnosed either after (47.17%) or simultaneously with thyroid dysfunction (27.68%). Proptosis (91.24%), eyelid retraction (83.33%), together with eyelid swelling (79.38%) and extraocular muscle enlargement (75.42%), were the most common clinical sign. 19.77% of patients manifested lower eyelid retraction. The mean values of exophthalmos and asymmetry on proptosis were 19.94±3.45mm and 2.18±2.06mm, respectively in males, 18.58±3.31mm and 1.61±1.53mm, respectively in females. The severity of disease was significantly associated with male, older age, smoking, family history of thyroid diseases and degree of proptosis. We found several differences in Chinese compared with White. The female-to-male ratio and mean value of exophthalmos were significantly lower than the data of White. Inferior and superior rectus became the most common extraocular muscles. Lower eyelid retraction should be included in diagnostic criteria in Asian patients. Understanding these differences, may allow better identification and treatment for TAO in China.

Citing Articles

Extraocular Muscle Enlargement in Thyroid Eye Disease Using Volumetric Analysis.

Park K, Li J, Wen J, Li S, Lee J, Danesh K Cureus. 2024; 16(7):e63843.

PMID: 39105029 PMC: 11298761. DOI: 10.7759/cureus.63843.


One Incremental Stride for Doxycycline, One Substantial Advancement for Thyroid Eye Disease.

Matoc I, Kasa K, Kasumovic A, Prpic A, Vukojevic A, Zrinscak O Diagnostics (Basel). 2024; 14(8).

PMID: 38667437 PMC: 11049125. DOI: 10.3390/diagnostics14080791.


Interrater reliability of photographic assessment of thyroid eye disease using the VISA classification.

Boynes A, Enright N, Hardy T, Khong J Int Ophthalmol. 2024; 44(1):98.

PMID: 38376802 PMC: 10879244. DOI: 10.1007/s10792-024-02934-z.


Predictive model for the progression of inactive thyroid eye disease: a retrospective study.

Qi L, Song X, Li Y, Sun J, Zhou H, Fan X Endocrine. 2023; 84(2):533-540.

PMID: 37936006 DOI: 10.1007/s12020-023-03582-6.


Roles of four targets in the pathogenesis of graves' orbitopathy.

Ren Z, Zhang H, Yu H, Zhu X, Lin J Heliyon. 2023; 9(9):e19250.

PMID: 37810014 PMC: 10558314. DOI: 10.1016/j.heliyon.2023.e19250.


References
1.
Bartley G, Gorman C . Diagnostic criteria for Graves' ophthalmopathy. Am J Ophthalmol. 1995; 119(6):792-5. DOI: 10.1016/s0002-9394(14)72787-4. View

2.
Bartalena L, Marcocci C, Tanda M, Manetti L, DellUnto E, Bartolomei M . Cigarette smoking and treatment outcomes in Graves ophthalmopathy. Ann Intern Med. 1998; 129(8):632-5. DOI: 10.7326/0003-4819-129-8-199810150-00010. View

3.
Rapoport B, McLachlan S . The thyrotropin receptor in Graves' disease. Thyroid. 2007; 17(10):911-22. DOI: 10.1089/thy.2007.0170. View

4.
Perros P, Zarkovic M, Azzolini C, Ayvaz G, Baldeschi L, Bartalena L . PREGO (presentation of Graves' orbitopathy) study: changes in referral patterns to European Group On Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012. Br J Ophthalmol. 2015; 99(11):1531-5. DOI: 10.1136/bjophthalmol-2015-306733. View

5.
Enzmann D, Donaldson S, KRISS J . Appearance of Graves' disease on orbital computed tomography. J Comput Assist Tomogr. 1979; 3(6):815-9. View